Urea: A review of scientific and clinical data

SKINmed

Volumn 8, Issue 2, 2010, Pages 102-106

  Scheinfeld, Noah S ^a  

^a School of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; DRUG VEHICLE; UREA;

CHEMISTRY; DRUG EFFECT; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; REVIEW; SKIN; VEHICLES;

COSMETICS; HUMANS; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; UREA; VEHICLES;

EID: 77954612958     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Features-beneficial effects of urea-information supplied by Beiersdorf. Talkeczema Web site. http://www.talkeczema.com/webpages/ features/feature_benefits_urea.htm. Accessed December 12, 2007.
2. Jacobi O. The composition of normal human stratum corneum and callus.
3. Lactic acid, creatine, creatinine, urea and choline. Arch Dermatol Forsch. 1970;240:107-118.
4. Wellner K, Wohlrab W. Quantitative evaluation of urea in stratum corneum of human skin. Arch Dermatol Res. 1993;285:239-240.
5. Barták P. The epidermal permeability barrier and its function in immune reactions [in Czech]. Cas Lek Cesk. 2001;140:259-261.
6. Sodium PCA. MetaGlossary Web site. http://www.metaglossary.com/meanings/1260977/. Accessed December 12, 2007.
7. Hagemann I, Proksch E. Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol. 1996;76:353-356.
8. Urea. DermNet NZ Web site. http://dermnetnz.org/treatments/ urea.html. Accessed December 12, 2007.
9. Buraczewska I, Berne B, Lindberg M, et al. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol. 2007;156:492-498.
10. Pham HT, Exelbert L, Segal-Owens AC, et al. A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ostomy Wound Manage. 2002;48:30-36.
11. Vlahovic T, Mills O. The cumulative effect of urea 40% combined with essential fatty acids in a bioadhesive delivery system and ketoconazole cream 2% for the treatment of moccasin tinea pedis in diabetics. J Am Acad Dermatol. 2007;56(2 suppl 2):AB45.
12. Momm F, Weissenberger C, Bartelt S, et al. Moist skin care can diminish acute radiation-induced skin toxicity. Strahlenther Onkol. 2003;179:708-712.
13. Serup J. A three-hour test for rapid comparison of effects of moisturizers and active constituents (urea). Measurement of hydration, scaling and skin surface lipidization by noninvasive techniques. Acta Derm Venereol Suppl (Stockh). 1992;177:29-33.
14. Fredriksson T, Gip L. Urea creams in the treatment of dry skin and hand dermatitis. Int J Dermatol. 1975;14:442-444.
15. Savica S, Tamburic S, Savic M, et al. Vehicle-controlled effect of urea on normal and SLS-irritated skin. Int J Pharm. 2004;271:269-280.
16. Kuzmina N, Hagströmer L, Emtestam L. Urea and sodium chloride in moisturisers for skin of the elderly-a comparative, double-blind, randomised study. Skin Pharmacol Appl Skin Physiol. 2002;15:166-174.
17. Horii I, Nakayama Y, Obata M, et al. Stratum corneum hydration and amino acid content in xerotic skin. Br J Dermatol. 1989;121:587-592.
18. Gloor M, Gehring W. Effects of emulsions on the stratum corneum barrier and hydration. Hautarzt. 2003;54:324-330.
19. Cramers M, Thormann J. Skin reactions to a urea-containing cream. Contact Dermatitis. 1981;7:189-191.
20. Stüttgen G. Results and consequences of long-term urea therapy for clinical practice. Hautarzt. 1992;43(suppl 11):9-12.
21. Küster W, Bohnsack K, Rippke F, et al. Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology. 1998;196:217-222.
22. Serup J. A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme. Acta Derm Venereol Suppl (Stockh). 1992;177:34-43.
23. Rizer R, Elias P, Mills OH. Urea (40%) in an essential fatty acid (EFA) vehicle improves barrier function in the stratum corneum (SC). J Am Acad Dermatol. 2006;54(3 suppl 1):602.
24. Kligman A, Stoudemayer S, Yaxian Zhen Y, et al. Improving chronically dry skin: Clinical, patient, and laboratory evaluations. J Am Acad Dermatol. 2006;54(3 suppl 1):571.
25. Bikowski J. The treatment of xerosis with a new 40% urea foam. J Am Acad Dermatol. 2007;56(2 suppl 2):AB40.
26. Gurge R. Evaluation of the aesthetic attributes of topical products containing high concentrations of urea. J Am Acad Dermatol. 2007;56(2 suppl 2):AB45.
27. Ademola J, Frazier C, Kim SJ, et al. Clinical evaluation of 40% urea and 12% ammonium lactate in the treatment of xerosis. Am J Clin Dermatol. 2002;3:217-222.